A randomized, double-blind, 4-way crossover, placebo-controlled, phase II study to evaluate the efficacy and safety of TAC-202/bilastine in Japanese cedar pollinosis exposure to antigen in an environmental exposure chamber (EEC).
Latest Information Update: 24 May 2016
At a glance
- Drugs Bilastine (Primary) ; Fexofenadine
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 20 Nov 2013 New trial record